---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-258064"
form_type: "8-K"
ticker: "TEVA"
cik: "0000818686"
company_name: "TEVA PHARMACEUTICAL INDUSTRIES LTD"
filed_at: "2021-08-27T23:59:59+00:00"
generated_at: "2026-06-29T07:25:44.298328+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Teva appoints Dr. Tal Zaks to Board of Directors, effective Oct 1, 2021

## Summary
- Dr. Tal Zaks elected to Teva Board, effective Oct 1, 2021, until 2022 annual meeting.
- Zaks joins from Moderna where he was Chief Medical Officer; departs late Sept 2021.
- Determined independent under NYSE rules; appointed to Science and Technology Committee.
- Will receive same compensation as other non-executive directors (see 2020 proxy).
- Zaks has MD/PhD, experience at Sanofi, Cephalon, GSK, and as adjunct professor at UPenn and Tufts.

## SEC filing metadata
- accession: 0001193125-21-258064
- form_type: 8-K
- ticker: TEVA
- cik: 0000818686
- company_name: TEVA PHARMACEUTICAL INDUSTRIES LTD
- filed_at: 2021-08-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818686/000119312521258064/0001193125-21-258064-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818686/000119312521258064/d224223d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-258064
- JSON: https://secwatch.observer/filing/0001193125-21-258064.json
- Plain text: https://secwatch.observer/filing/0001193125-21-258064.txt

## Key facts
- Executive change
  Dr. Tal Zaks was elected as Member of the Board at TEVA PHARMACEUTICAL INDUSTRIES LTD.
  - Action: elected
  - Role: Member of the Board
  source text: elected Dr. Tal Zaks to serve as a member of the Board, effective October 1, 2021
  evidence_url: https://www.sec.gov/Archives/edgar/data/818686/000119312521258064/0001193125-21-258064-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.